Lv3
292 积分 2026-02-27 加入
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
5个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
5个月前
已完结
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
6个月前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
6个月前
已完结
Engineering sonogenetic EchoBack-CAR T cells
6个月前
已完结
CAR-T therapy in solid tumors
6个月前
已完结
皖公网安备34019202002308
